Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Mandy Sakamoto

Concepts (54)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Non-Small-Cell Lung
5
2024
1191
1.300
Why?
Lung Neoplasms
5
2024
2667
0.960
Why?
Benzodiazepines
1
2021
168
0.600
Why?
Lactams, Macrocyclic
1
2018
51
0.560
Why?
Organophosphorus Compounds
1
2018
84
0.530
Why?
Central Nervous System
1
2018
282
0.480
Why?
Pyrimidines
2
2024
530
0.470
Why?
Analgesics, Opioid
1
2021
1154
0.350
Why?
Antineoplastic Agents
2
2021
2219
0.330
Why?
Breast Neoplasms
1
2021
2393
0.270
Why?
Pemetrexed
1
2024
40
0.210
Why?
Acrylamides
1
2024
74
0.210
Why?
Mutation
3
2024
4090
0.200
Why?
Aniline Compounds
1
2024
120
0.200
Why?
Proto-Oncogene Proteins c-met
1
2023
76
0.180
Why?
Neoplasm Metastasis
2
2024
688
0.160
Why?
B7-H1 Antigen
1
2023
244
0.160
Why?
SEER Program
1
2021
230
0.150
Why?
Lactams
1
2018
28
0.140
Why?
Drug Approval
1
2018
93
0.140
Why?
Molecular Targeted Therapy
1
2021
440
0.140
Why?
Protein-Tyrosine Kinases
1
2021
431
0.130
Why?
Aminopyridines
1
2018
129
0.130
Why?
Proto-Oncogene Proteins
1
2021
625
0.130
Why?
Antibodies, Monoclonal, Humanized
1
2023
992
0.120
Why?
Protein Kinase Inhibitors
1
2023
981
0.120
Why?
Recurrence
1
2018
1139
0.110
Why?
Medicare
1
2021
904
0.110
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2024
1969
0.110
Why?
Pyrazoles
1
2018
517
0.110
Why?
Opioid-Related Disorders
1
2021
605
0.090
Why?
Dermatology
1
2012
131
0.080
Why?
Humans
7
2024
145750
0.080
Why?
Retrospective Studies
2
2024
17322
0.060
Why?
Referral and Consultation
1
2012
868
0.060
Why?
Treatment Outcome
2
2018
11793
0.060
Why?
United States
2
2021
16122
0.050
Why?
Telemedicine
1
2012
963
0.050
Why?
ErbB Receptors
1
2024
635
0.040
Why?
Indoles
1
2024
507
0.040
Why?
Adult
2
2024
40867
0.040
Why?
Disease Progression
1
2024
2865
0.030
Why?
Female
2
2024
79025
0.030
Why?
Male
2
2024
72992
0.030
Why?
Drug Resistance, Neoplasm
1
2021
883
0.030
Why?
Northwestern United States
1
2012
58
0.020
Why?
Health Records, Personal
1
2012
26
0.020
Why?
Aged, 80 and over
1
2024
8346
0.020
Why?
Medically Underserved Area
1
2012
100
0.020
Why?
Remote Consultation
1
2012
66
0.020
Why?
Rural Health Services
1
2012
138
0.020
Why?
Aged
1
2024
26212
0.010
Why?
Middle Aged
1
2024
36297
0.010
Why?
Veterans
1
2012
1639
0.010
Why?
Sakamoto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)